The Sacklers Want Immunity From The Opioid Crisis For A Long List Of Their Associates
In the Purdue Pharma bankruptcy trial now underway, scrutiny has focused on the Sacklers' demand for immunity from opioid lawsuits that would extend to a vast network of individuals and businesses.
Buried at the bottom of reams of legal documents filed as part of the Purdue Pharma bankruptcy case is a single-spaced list that goes on for more than a dozen pages.
It details hundreds of individuals, companies, trusts and other organizations, including financial advisers, public relations firms, law firms, lobbyists, drug makers and laboratories.
If members of the Sackler family who own Purdue Pharma get their way, everyone on the list will win sweeping immunity from civil lawsuits linked to the family's activities, the sale of OxyContin, or Purdue Pharma's other operations.
This demand by the Sacklers for a legal firewall surrounding themselves and their sprawling network has emerged as a flashpoint in the federal bankruptcy
